s6y
Company name or ticker
Search
Opus Genetics, Inc.
5
Ainsworth Sean: Annual statement of changes in beneficial ownership of securities
Filed
Monday, February 14, 2022
Period
Dec 31, 2021
Accession number
0001140361-22-005102
Documents
FORM 5
5
On sec.gov
Filing index
All files
Complete submission text
SGML header